MidWestOne Financial Group Inc. Has $592,000 Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

MidWestOne Financial Group Inc. lessened its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 61.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 27,984 shares of the company's stock after selling 45,518 shares during the period. MidWestOne Financial Group Inc.'s holdings in Surgery Partners were worth $592,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of SGRY. KBC Group NV raised its position in shares of Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after purchasing an additional 1,577 shares during the period. State of Wyoming raised its position in shares of Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its position in shares of Surgery Partners by 12.1% during the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after purchasing an additional 465 shares during the period. MeadowBrook Investment Advisors LLC raised its position in shares of Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after purchasing an additional 1,460 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Surgery Partners by 279.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock worth $228,000 after purchasing an additional 7,925 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Macquarie dropped their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 11th. Benchmark restated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Tuesday, March 25th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $34.75.

Surgery Partners Stock Performance

SGRY traded up $0.20 during trading hours on Friday, hitting $22.80. The company's stock had a trading volume of 692,258 shares, compared to its average volume of 1,101,749. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The firm has a market capitalization of $2.92 billion, a PE ratio of -47.50, a PEG ratio of 19.21 and a beta of 1.96. The company has a 50-day simple moving average of $22.46 and a 200 day simple moving average of $22.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. During the same quarter last year, the business posted $0.10 earnings per share. The firm's revenue for the quarter was up 8.2% compared to the same quarter last year. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Activity

In other news, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. This trade represents a 4.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO David T. Doherty sold 6,733 shares of the firm's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at approximately $3,623,849.36. This represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is owned by insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.